Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Allograft rejection 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40 [1] CD40 💬Allograft rejection
|
Bleselumab Bleselumab 💬Allograft rejection
| Bleselumab | 222 [1] 222 💬1. Allograft rejection
|
||||||||||||||||||||||||||||||||||||
| 2 | Allograft rejection 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40 [1] CD40 💬Allograft rejection
|
Iscalimab Iscalimab 💬Allograft rejection
| Iscalimab | 049 [2] 49, 53 💬
|
||||||||||||||||||||||||||||||||||||
| 3 | Allograft rejection 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40 [1] CD40 💬Allograft rejection
|
Ravagalimab Ravagalimab 💬Allograft rejection
| Ravagalimab | 046 [3] 46, 53, 97 💬
|
||||||||||||||||||||||||||||||||||||
| 4 | Allograft rejection 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40LG [1] CD40LG 💬Allograft rejection
|
Frexalimab Frexalimab 💬Allograft rejection
| Frexalimab | 013 [2] 13, 222 💬4. Allograft rejection
|
||||||||||||||||||||||||||||||||||||
| 5 | Allograft rejection 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40LG [1] CD40LG 💬Allograft rejection
|
Toralizumab Toralizumab 💬Allograft rejection
| Toralizumab | 063 [1] 63 💬5. Allograft rejection
|
||||||||||||||||||||||||||||||||||||
| 6 | Antigen processing and presentation 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Antigen processing and presentation
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Antigen processing and presentation
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬6. Antigen processing and presentation
|
||||||||||||||||||||||||||||||||||||
| 7 | Antigen processing and presentation 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Antigen processing and presentation
|
Zanolimumab Zanolimumab 💬Antigen processing and presentation
| Zanolimumab | 046 [1] 46 💬7. Antigen processing and presentation
|
||||||||||||||||||||||||||||||||||||
| 8 | Asthma 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40 [1] CD40 💬Asthma
|
Bleselumab Bleselumab 💬Asthma
| Bleselumab | 222 [1] 222 💬8. Asthma
|
||||||||||||||||||||||||||||||||||||
| 9 | Asthma 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40 [1] CD40 💬Asthma
|
Iscalimab Iscalimab 💬Asthma
| Iscalimab | 049 [2] 49, 53 💬
|
||||||||||||||||||||||||||||||||||||
| 10 | Asthma 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40 [1] CD40 💬Asthma
|
Ravagalimab Ravagalimab 💬Asthma
| Ravagalimab | 046 [3] 46, 53, 97 💬
|
||||||||||||||||||||||||||||||||||||
| 11 | Asthma 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40LG [1] CD40LG 💬Asthma
|
Frexalimab Frexalimab 💬Asthma
| Frexalimab | 013 [2] 13, 222 💬11. Asthma
|
||||||||||||||||||||||||||||||||||||
| 12 | Asthma 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40LG [1] CD40LG 💬Asthma
|
Toralizumab Toralizumab 💬Asthma
| Toralizumab | 063 [1] 63 💬12. Asthma
|
||||||||||||||||||||||||||||||||||||
| 13 | Autoimmune thyroid disease 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40 [1] CD40 💬Autoimmune thyroid disease
|
Bleselumab Bleselumab 💬Autoimmune thyroid disease
| Bleselumab | 222 [1] 222 💬13. Autoimmune thyroid disease
|
||||||||||||||||||||||||||||||||||||
| 14 | Autoimmune thyroid disease 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40 [1] CD40 💬Autoimmune thyroid disease
|
Iscalimab Iscalimab 💬Autoimmune thyroid disease
| Iscalimab | 049 [2] 49, 53 💬
|
||||||||||||||||||||||||||||||||||||
| 15 | Autoimmune thyroid disease 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40 [1] CD40 💬Autoimmune thyroid disease
|
Ravagalimab Ravagalimab 💬Autoimmune thyroid disease
| Ravagalimab | 046 [3] 46, 53, 97 💬15. Autoimmune thyroid disease |
||||||||||||||||||||||||||||||||||||
| 16 | Autoimmune thyroid disease 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40LG [1] CD40LG 💬Autoimmune thyroid disease
|
Frexalimab Frexalimab 💬Autoimmune thyroid disease
| Frexalimab | 013 [2] 13, 222 💬16. Autoimmune thyroid disease
|
||||||||||||||||||||||||||||||||||||
| 17 | Autoimmune thyroid disease 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40LG [1] CD40LG 💬Autoimmune thyroid disease
|
Toralizumab Toralizumab 💬Autoimmune thyroid disease
| Toralizumab | 063 [1] 63 💬17. Autoimmune thyroid disease
|
||||||||||||||||||||||||||||||||||||
| 18 | Cell adhesion molecules 💬 3 genes, 7 drugs (DrugBank) and 18 diseases |
CD4 [1] CD4 💬Cell adhesion molecules
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Cell adhesion molecules
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬18. Cell adhesion molecules
|
||||||||||||||||||||||||||||||||||||
| 19 | Cell adhesion molecules 💬 3 genes, 7 drugs (DrugBank) and 18 diseases |
CD4 [1] CD4 💬Cell adhesion molecules
|
Zanolimumab Zanolimumab 💬Cell adhesion molecules
| Zanolimumab | 046 [1] 46 💬19. Cell adhesion molecules
|
||||||||||||||||||||||||||||||||||||
| 20 | Cell adhesion molecules 💬 3 genes, 7 drugs (DrugBank) and 18 diseases |
CD40 [1] CD40 💬Cell adhesion molecules
|
Bleselumab Bleselumab 💬Cell adhesion molecules
| Bleselumab | 222 [1] 222 💬20. Cell adhesion molecules
|
||||||||||||||||||||||||||||||||||||
| 21 | Cell adhesion molecules 💬 3 genes, 7 drugs (DrugBank) and 18 diseases |
CD40 [1] CD40 💬Cell adhesion molecules
|
Iscalimab Iscalimab 💬Cell adhesion molecules
| Iscalimab | 049 [2] 49, 53 💬
|
||||||||||||||||||||||||||||||||||||
| 22 | Cell adhesion molecules 💬 3 genes, 7 drugs (DrugBank) and 18 diseases |
CD40 [1] CD40 💬Cell adhesion molecules
|
Ravagalimab Ravagalimab 💬Cell adhesion molecules
| Ravagalimab | 046 [3] 46, 53, 97 💬
|
||||||||||||||||||||||||||||||||||||
| 23 | Cell adhesion molecules 💬 3 genes, 7 drugs (DrugBank) and 18 diseases |
CD40LG [1] CD40LG 💬Cell adhesion molecules
|
Frexalimab Frexalimab 💬Cell adhesion molecules
| Frexalimab | 013 [2] 13, 222 💬23. Cell adhesion molecules
|
||||||||||||||||||||||||||||||||||||
| 24 | Cell adhesion molecules 💬 3 genes, 7 drugs (DrugBank) and 18 diseases |
CD40LG [1] CD40LG 💬Cell adhesion molecules
|
Toralizumab Toralizumab 💬Cell adhesion molecules
| Toralizumab | 063 [1] 63 💬24. Cell adhesion molecules
|
||||||||||||||||||||||||||||||||||||
| 25 | Cytokine-cytokine receptor interaction 💬 3 genes, 7 drugs (DrugBank) and 18 diseases |
CD4 [1] CD4 💬Cytokine-cytokine receptor interaction
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Cytokine-cytokine receptor interaction
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬25. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||
| 26 | Cytokine-cytokine receptor interaction 💬 3 genes, 7 drugs (DrugBank) and 18 diseases |
CD4 [1] CD4 💬Cytokine-cytokine receptor interaction
|
Zanolimumab Zanolimumab 💬Cytokine-cytokine receptor interaction
| Zanolimumab | 046 [1] 46 💬26. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||
| 27 | Cytokine-cytokine receptor interaction 💬 3 genes, 7 drugs (DrugBank) and 18 diseases |
CD40 [1] CD40 💬Cytokine-cytokine receptor interaction
|
Bleselumab Bleselumab 💬Cytokine-cytokine receptor interaction
| Bleselumab | 222 [1] 222 💬27. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||
| 28 | Cytokine-cytokine receptor interaction 💬 3 genes, 7 drugs (DrugBank) and 18 diseases |
CD40 [1] CD40 💬Cytokine-cytokine receptor interaction
|
Iscalimab Iscalimab 💬Cytokine-cytokine receptor interaction
| Iscalimab | 049 [2] 49, 53 💬
|
||||||||||||||||||||||||||||||||||||
| 29 | Cytokine-cytokine receptor interaction 💬 3 genes, 7 drugs (DrugBank) and 18 diseases |
CD40 [1] CD40 💬Cytokine-cytokine receptor interaction
|
Ravagalimab Ravagalimab 💬Cytokine-cytokine receptor interaction
| Ravagalimab | 046 [3] 46, 53, 97 💬29. Cytokine-cytokine receptor interaction |
||||||||||||||||||||||||||||||||||||
| 30 | Cytokine-cytokine receptor interaction 💬 3 genes, 7 drugs (DrugBank) and 18 diseases |
CD40LG [1] CD40LG 💬Cytokine-cytokine receptor interaction
|
Frexalimab Frexalimab 💬Cytokine-cytokine receptor interaction
| Frexalimab | 013 [2] 13, 222 💬30. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||
| 31 | Cytokine-cytokine receptor interaction 💬 3 genes, 7 drugs (DrugBank) and 18 diseases |
CD40LG [1] CD40LG 💬Cytokine-cytokine receptor interaction
|
Toralizumab Toralizumab 💬Cytokine-cytokine receptor interaction
| Toralizumab | 063 [1] 63 💬31. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||
| 32 | Epstein-Barr virus infection 💬 1 gene, 3 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬Epstein-Barr virus infection
|
Bleselumab Bleselumab 💬Epstein-Barr virus infection
| Bleselumab | 222 [1] 222 💬32. Epstein-Barr virus infection
|
||||||||||||||||||||||||||||||||||||
| 33 | Epstein-Barr virus infection 💬 1 gene, 3 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬Epstein-Barr virus infection
|
Iscalimab Iscalimab 💬Epstein-Barr virus infection
| Iscalimab | 049 [2] 49, 53 💬
|
||||||||||||||||||||||||||||||||||||
| 34 | Epstein-Barr virus infection 💬 1 gene, 3 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬Epstein-Barr virus infection
|
Ravagalimab Ravagalimab 💬Epstein-Barr virus infection
| Ravagalimab | 046 [3] 46, 53, 97 💬34. Epstein-Barr virus infection |
||||||||||||||||||||||||||||||||||||
| 35 | Hematopoietic cell lineage 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Hematopoietic cell lineage
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Hematopoietic cell lineage
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬35. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||
| 36 | Hematopoietic cell lineage 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Hematopoietic cell lineage
|
Zanolimumab Zanolimumab 💬Hematopoietic cell lineage
| Zanolimumab | 046 [1] 46 💬36. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||
| 37 | Human immunodeficiency virus 1 infection 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Hematopoietic cell lineage
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Human immunodeficiency virus 1 infection
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬37. Human immunodeficiency virus 1 infection
|
||||||||||||||||||||||||||||||||||||
| 38 | Human immunodeficiency virus 1 infection 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Hematopoietic cell lineage
|
Zanolimumab Zanolimumab 💬Human immunodeficiency virus 1 infection
| Zanolimumab | 046 [1] 46 💬38. Human immunodeficiency virus 1 infection
|
||||||||||||||||||||||||||||||||||||
| 39 | Human T-cell leukemia virus 1 infection 💬 2 genes, 5 drugs (DrugBank) and 17 diseases |
CD4 [1] CD4 💬Hematopoietic cell lineage
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Human T-cell leukemia virus 1 infection
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬39. Human T-cell leukemia virus 1 infection
|
||||||||||||||||||||||||||||||||||||
| 40 | Human T-cell leukemia virus 1 infection 💬 2 genes, 5 drugs (DrugBank) and 17 diseases |
CD4 [1] CD4 💬Hematopoietic cell lineage
|
Zanolimumab Zanolimumab 💬Human T-cell leukemia virus 1 infection
| Zanolimumab | 046 [1] 46 💬40. Human T-cell leukemia virus 1 infection
|
||||||||||||||||||||||||||||||||||||
| 41 | Human T-cell leukemia virus 1 infection 💬 2 genes, 5 drugs (DrugBank) and 17 diseases |
CD40 [1] CD40 💬Human T-cell leukemia virus 1 infection
|
Bleselumab Bleselumab 💬Human T-cell leukemia virus 1 infection
| Bleselumab | 222 [1] 222 💬41. Human T-cell leukemia virus 1 infection
|
||||||||||||||||||||||||||||||||||||
| 42 | Human T-cell leukemia virus 1 infection 💬 2 genes, 5 drugs (DrugBank) and 17 diseases |
CD40 [1] CD40 💬Human T-cell leukemia virus 1 infection
|
Iscalimab Iscalimab 💬Human T-cell leukemia virus 1 infection
| Iscalimab | 049 [2] 49, 53 💬
|
||||||||||||||||||||||||||||||||||||
| 43 | Human T-cell leukemia virus 1 infection 💬 2 genes, 5 drugs (DrugBank) and 17 diseases |
CD40 [1] CD40 💬Human T-cell leukemia virus 1 infection
|
Ravagalimab Ravagalimab 💬Human T-cell leukemia virus 1 infection
| Ravagalimab | 046 [3] 46, 53, 97 💬43. Human T-cell leukemia virus 1 infection |
||||||||||||||||||||||||||||||||||||
| 44 | Intestinal immune network for IgA production 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40 [1] CD40 💬Human T-cell leukemia virus 1 infection
|
Bleselumab Bleselumab 💬Intestinal immune network for IgA production
| Bleselumab | 222 [1] 222 💬44. Intestinal immune network for IgA production
|
||||||||||||||||||||||||||||||||||||
| 45 | Intestinal immune network for IgA production 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40 [1] CD40 💬Human T-cell leukemia virus 1 infection
|
Iscalimab Iscalimab 💬Intestinal immune network for IgA production
| Iscalimab | 049 [2] 49, 53 💬
|
||||||||||||||||||||||||||||||||||||
| 46 | Intestinal immune network for IgA production 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40 [1] CD40 💬Human T-cell leukemia virus 1 infection
|
Ravagalimab Ravagalimab 💬Intestinal immune network for IgA production
| Ravagalimab | 046 [3] 46, 53, 97 💬46. Intestinal immune network for IgA production |
||||||||||||||||||||||||||||||||||||
| 47 | Intestinal immune network for IgA production 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40LG [1] CD40LG 💬Intestinal immune network for IgA production
|
Frexalimab Frexalimab 💬Intestinal immune network for IgA production
| Frexalimab | 013 [2] 13, 222 💬47. Intestinal immune network for IgA production
|
||||||||||||||||||||||||||||||||||||
| 48 | Intestinal immune network for IgA production 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40LG [1] CD40LG 💬Intestinal immune network for IgA production
|
Toralizumab Toralizumab 💬Intestinal immune network for IgA production
| Toralizumab | 063 [1] 63 💬48. Intestinal immune network for IgA production
|
||||||||||||||||||||||||||||||||||||
| 49 | Lipid and atherosclerosis 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40 [1] CD40 💬Lipid and atherosclerosis
|
Bleselumab Bleselumab 💬Lipid and atherosclerosis
| Bleselumab | 222 [1] 222 💬49. Lipid and atherosclerosis
|
||||||||||||||||||||||||||||||||||||
| 50 | Lipid and atherosclerosis 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40 [1] CD40 💬Lipid and atherosclerosis
|
Iscalimab Iscalimab 💬Lipid and atherosclerosis
| Iscalimab | 049 [2] 49, 53 💬
|
||||||||||||||||||||||||||||||||||||
| 51 | Lipid and atherosclerosis 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40 [1] CD40 💬Lipid and atherosclerosis
|
Ravagalimab Ravagalimab 💬Lipid and atherosclerosis
| Ravagalimab | 046 [3] 46, 53, 97 💬51. Lipid and atherosclerosis |
||||||||||||||||||||||||||||||||||||
| 52 | Lipid and atherosclerosis 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40LG [1] CD40LG 💬Lipid and atherosclerosis
|
Frexalimab Frexalimab 💬Lipid and atherosclerosis
| Frexalimab | 013 [2] 13, 222 💬52. Lipid and atherosclerosis
|
||||||||||||||||||||||||||||||||||||
| 53 | Lipid and atherosclerosis 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40LG [1] CD40LG 💬Lipid and atherosclerosis
|
Toralizumab Toralizumab 💬Lipid and atherosclerosis
| Toralizumab | 063 [1] 63 💬53. Lipid and atherosclerosis
|
||||||||||||||||||||||||||||||||||||
| 54 | Malaria 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40 [1] CD40 💬Malaria
|
Bleselumab Bleselumab 💬Malaria
| Bleselumab | 222 [1] 222 💬54. Malaria
|
||||||||||||||||||||||||||||||||||||
| 55 | Malaria 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40 [1] CD40 💬Malaria
|
Iscalimab Iscalimab 💬Malaria
| Iscalimab | 049 [2] 49, 53 💬
|
||||||||||||||||||||||||||||||||||||
| 56 | Malaria 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40 [1] CD40 💬Malaria
|
Ravagalimab Ravagalimab 💬Malaria
| Ravagalimab | 046 [3] 46, 53, 97 💬
|
||||||||||||||||||||||||||||||||||||
| 57 | Malaria 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40LG [1] CD40LG 💬Malaria
|
Frexalimab Frexalimab 💬Malaria
| Frexalimab | 013 [2] 13, 222 💬57. Malaria
|
||||||||||||||||||||||||||||||||||||
| 58 | Malaria 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40LG [1] CD40LG 💬Malaria
|
Toralizumab Toralizumab 💬Malaria
| Toralizumab | 063 [1] 63 💬58. Malaria
|
||||||||||||||||||||||||||||||||||||
| 59 | NF-kappa B signaling pathway 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40 [1] CD40 💬NF-kappa B signaling pathway
|
Bleselumab Bleselumab 💬NF-kappa B signaling pathway
| Bleselumab | 222 [1] 222 💬59. NF-kappa B signaling pathway
|
||||||||||||||||||||||||||||||||||||
| 60 | NF-kappa B signaling pathway 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40 [1] CD40 💬NF-kappa B signaling pathway
|
Iscalimab Iscalimab 💬NF-kappa B signaling pathway
| Iscalimab | 049 [2] 49, 53 💬
|
||||||||||||||||||||||||||||||||||||
| 61 | NF-kappa B signaling pathway 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40 [1] CD40 💬NF-kappa B signaling pathway
|
Ravagalimab Ravagalimab 💬NF-kappa B signaling pathway
| Ravagalimab | 046 [3] 46, 53, 97 💬61. NF-kappa B signaling pathway |
||||||||||||||||||||||||||||||||||||
| 62 | NF-kappa B signaling pathway 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40LG [1] CD40LG 💬NF-kappa B signaling pathway
|
Frexalimab Frexalimab 💬NF-kappa B signaling pathway
| Frexalimab | 013 [2] 13, 222 💬62. NF-kappa B signaling pathway
|
||||||||||||||||||||||||||||||||||||
| 63 | NF-kappa B signaling pathway 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40LG [1] CD40LG 💬NF-kappa B signaling pathway
|
Toralizumab Toralizumab 💬NF-kappa B signaling pathway
| Toralizumab | 063 [1] 63 💬63. NF-kappa B signaling pathway
|
||||||||||||||||||||||||||||||||||||
| 64 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬64. PD-L1 expression and PD-1 checkpoint pathway in cancer
|
||||||||||||||||||||||||||||||||||||
| 65 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
|
Zanolimumab Zanolimumab 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
| Zanolimumab | 046 [1] 46 💬65. PD-L1 expression and PD-1 checkpoint pathway in cancer
|
||||||||||||||||||||||||||||||||||||
| 66 | Primary immunodeficiency 💬 3 genes, 7 drugs (DrugBank) and 18 diseases |
CD4 [1] CD4 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Primary immunodeficiency
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬66. Primary immunodeficiency
|
||||||||||||||||||||||||||||||||||||
| 67 | Primary immunodeficiency 💬 3 genes, 7 drugs (DrugBank) and 18 diseases |
CD4 [1] CD4 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
|
Zanolimumab Zanolimumab 💬Primary immunodeficiency
| Zanolimumab | 046 [1] 46 💬67. Primary immunodeficiency
|
||||||||||||||||||||||||||||||||||||
| 68 | Primary immunodeficiency 💬 3 genes, 7 drugs (DrugBank) and 18 diseases |
CD40 [1] CD40 💬Primary immunodeficiency
|
Bleselumab Bleselumab 💬Primary immunodeficiency
| Bleselumab | 222 [1] 222 💬68. Primary immunodeficiency
|
||||||||||||||||||||||||||||||||||||
| 69 | Primary immunodeficiency 💬 3 genes, 7 drugs (DrugBank) and 18 diseases |
CD40 [1] CD40 💬Primary immunodeficiency
|
Iscalimab Iscalimab 💬Primary immunodeficiency
| Iscalimab | 049 [2] 49, 53 💬
|
||||||||||||||||||||||||||||||||||||
| 70 | Primary immunodeficiency 💬 3 genes, 7 drugs (DrugBank) and 18 diseases |
CD40 [1] CD40 💬Primary immunodeficiency
|
Ravagalimab Ravagalimab 💬Primary immunodeficiency
| Ravagalimab | 046 [3] 46, 53, 97 💬
|
||||||||||||||||||||||||||||||||||||
| 71 | Primary immunodeficiency 💬 3 genes, 7 drugs (DrugBank) and 18 diseases |
CD40LG [1] CD40LG 💬Primary immunodeficiency
|
Frexalimab Frexalimab 💬Primary immunodeficiency
| Frexalimab | 013 [2] 13, 222 💬71. Primary immunodeficiency
|
||||||||||||||||||||||||||||||||||||
| 72 | Primary immunodeficiency 💬 3 genes, 7 drugs (DrugBank) and 18 diseases |
CD40LG [1] CD40LG 💬Primary immunodeficiency
|
Toralizumab Toralizumab 💬Primary immunodeficiency
| Toralizumab | 063 [1] 63 💬72. Primary immunodeficiency
|
||||||||||||||||||||||||||||||||||||
| 73 | Systemic lupus erythematosus 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40 [1] CD40 💬Systemic lupus erythematosus
|
Bleselumab Bleselumab 💬Systemic lupus erythematosus
| Bleselumab | 222 [1] 222 💬73. Systemic lupus erythematosus
|
||||||||||||||||||||||||||||||||||||
| 74 | Systemic lupus erythematosus 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40 [1] CD40 💬Systemic lupus erythematosus
|
Iscalimab Iscalimab 💬Systemic lupus erythematosus
| Iscalimab | 049 [2] 49, 53 💬
|
||||||||||||||||||||||||||||||||||||
| 75 | Systemic lupus erythematosus 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40 [1] CD40 💬Systemic lupus erythematosus
|
Ravagalimab Ravagalimab 💬Systemic lupus erythematosus
| Ravagalimab | 046 [3] 46, 53, 97 💬75. Systemic lupus erythematosus |
||||||||||||||||||||||||||||||||||||
| 76 | Systemic lupus erythematosus 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40LG [1] CD40LG 💬Systemic lupus erythematosus
|
Frexalimab Frexalimab 💬Systemic lupus erythematosus
| Frexalimab | 013 [2] 13, 222 💬76. Systemic lupus erythematosus
|
||||||||||||||||||||||||||||||||||||
| 77 | Systemic lupus erythematosus 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40LG [1] CD40LG 💬Systemic lupus erythematosus
|
Toralizumab Toralizumab 💬Systemic lupus erythematosus
| Toralizumab | 063 [1] 63 💬77. Systemic lupus erythematosus
|
||||||||||||||||||||||||||||||||||||
| 78 | T cell receptor signaling pathway 💬 2 genes, 4 drugs (DrugBank) and 16 diseases |
CD4 [1] CD4 💬T cell receptor signaling pathway
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬T cell receptor signaling pathway
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬78. T cell receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||
| 79 | T cell receptor signaling pathway 💬 2 genes, 4 drugs (DrugBank) and 16 diseases |
CD4 [1] CD4 💬T cell receptor signaling pathway
|
Zanolimumab Zanolimumab 💬T cell receptor signaling pathway
| Zanolimumab | 046 [1] 46 💬79. T cell receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||
| 80 | T cell receptor signaling pathway 💬 2 genes, 4 drugs (DrugBank) and 16 diseases |
CD40LG [1] CD40LG 💬T cell receptor signaling pathway
|
Frexalimab Frexalimab 💬T cell receptor signaling pathway
| Frexalimab | 013 [2] 13, 222 💬80. T cell receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||
| 81 | T cell receptor signaling pathway 💬 2 genes, 4 drugs (DrugBank) and 16 diseases |
CD40LG [1] CD40LG 💬T cell receptor signaling pathway
|
Toralizumab Toralizumab 💬T cell receptor signaling pathway
| Toralizumab | 063 [1] 63 💬81. T cell receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||
| 82 | Th1 and Th2 cell differentiation 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Th1 and Th2 cell differentiation
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Th1 and Th2 cell differentiation
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬82. Th1 and Th2 cell differentiation
|
||||||||||||||||||||||||||||||||||||
| 83 | Th1 and Th2 cell differentiation 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Th1 and Th2 cell differentiation
|
Zanolimumab Zanolimumab 💬Th1 and Th2 cell differentiation
| Zanolimumab | 046 [1] 46 💬83. Th1 and Th2 cell differentiation
|
||||||||||||||||||||||||||||||||||||
| 84 | Th17 cell differentiation 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Th1 and Th2 cell differentiation
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Th17 cell differentiation
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬84. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||
| 85 | Th17 cell differentiation 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Th1 and Th2 cell differentiation
|
Zanolimumab Zanolimumab 💬Th17 cell differentiation
| Zanolimumab | 046 [1] 46 💬85. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||
| 86 | Toll-like receptor signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬Toll-like receptor signaling pathway
|
Bleselumab Bleselumab 💬Toll-like receptor signaling pathway
| Bleselumab | 222 [1] 222 💬86. Toll-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||
| 87 | Toll-like receptor signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬Toll-like receptor signaling pathway
|
Iscalimab Iscalimab 💬Toll-like receptor signaling pathway
| Iscalimab | 049 [2] 49, 53 💬
|
||||||||||||||||||||||||||||||||||||
| 88 | Toll-like receptor signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬Toll-like receptor signaling pathway
|
Ravagalimab Ravagalimab 💬Toll-like receptor signaling pathway
| Ravagalimab | 046 [3] 46, 53, 97 💬88. Toll-like receptor signaling pathway |
||||||||||||||||||||||||||||||||||||
| 89 | Toxoplasmosis 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40 [1] CD40 💬Toll-like receptor signaling pathway
|
Bleselumab Bleselumab 💬Toxoplasmosis
| Bleselumab | 222 [1] 222 💬89. Toxoplasmosis
|
||||||||||||||||||||||||||||||||||||
| 90 | Toxoplasmosis 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40 [1] CD40 💬Toll-like receptor signaling pathway
|
Iscalimab Iscalimab 💬Toxoplasmosis
| Iscalimab | 049 [2] 49, 53 💬
|
||||||||||||||||||||||||||||||||||||
| 91 | Toxoplasmosis 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40 [1] CD40 💬Toll-like receptor signaling pathway
|
Ravagalimab Ravagalimab 💬Toxoplasmosis
| Ravagalimab | 046 [3] 46, 53, 97 💬
|
||||||||||||||||||||||||||||||||||||
| 92 | Toxoplasmosis 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40LG [1] CD40LG 💬Toxoplasmosis
|
Frexalimab Frexalimab 💬Toxoplasmosis
| Frexalimab | 013 [2] 13, 222 💬92. Toxoplasmosis
|
||||||||||||||||||||||||||||||||||||
| 93 | Toxoplasmosis 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40LG [1] CD40LG 💬Toxoplasmosis
|
Toralizumab Toralizumab 💬Toxoplasmosis
| Toralizumab | 063 [1] 63 💬93. Toxoplasmosis
|
||||||||||||||||||||||||||||||||||||
| 94 | Transcriptional misregulation in cancer 💬 1 gene, 3 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬Transcriptional misregulation in cancer
|
Bleselumab Bleselumab 💬Transcriptional misregulation in cancer
| Bleselumab | 222 [1] 222 💬94. Transcriptional misregulation in cancer
|
||||||||||||||||||||||||||||||||||||
| 95 | Transcriptional misregulation in cancer 💬 1 gene, 3 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬Transcriptional misregulation in cancer
|
Iscalimab Iscalimab 💬Transcriptional misregulation in cancer
| Iscalimab | 049 [2] 49, 53 💬
|
||||||||||||||||||||||||||||||||||||
| 96 | Transcriptional misregulation in cancer 💬 1 gene, 3 drugs (DrugBank) and 5 diseases |
CD40 [1] CD40 💬Transcriptional misregulation in cancer
|
Ravagalimab Ravagalimab 💬Transcriptional misregulation in cancer
| Ravagalimab | 046 [3] 46, 53, 97 💬96. Transcriptional misregulation in cancer |
||||||||||||||||||||||||||||||||||||
| 97 | Viral life cycle - HIV-1 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Viral life cycle - HIV-1
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Viral life cycle - HIV-1
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬97. Viral life cycle - HIV-1
|
||||||||||||||||||||||||||||||||||||
| 98 | Viral life cycle - HIV-1 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Viral life cycle - HIV-1
|
Zanolimumab Zanolimumab 💬Viral life cycle - HIV-1
| Zanolimumab | 046 [1] 46 💬98. Viral life cycle - HIV-1
|
||||||||||||||||||||||||||||||||||||
| 99 | Viral myocarditis 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40 [1] CD40 💬Viral myocarditis
|
Bleselumab Bleselumab 💬Viral myocarditis
| Bleselumab | 222 [1] 222 💬99. Viral myocarditis
|
||||||||||||||||||||||||||||||||||||
| 100 | Viral myocarditis 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40 [1] CD40 💬Viral myocarditis
|
Iscalimab Iscalimab 💬Viral myocarditis
| Iscalimab | 049 [2] 49, 53 💬
|
||||||||||||||||||||||||||||||||||||
| 101 | Viral myocarditis 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40 [1] CD40 💬Viral myocarditis
|
Ravagalimab Ravagalimab 💬Viral myocarditis
| Ravagalimab | 046 [3] 46, 53, 97 💬
|
||||||||||||||||||||||||||||||||||||
| 102 | Viral myocarditis 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40LG [1] CD40LG 💬Viral myocarditis
|
Frexalimab Frexalimab 💬Viral myocarditis
| Frexalimab | 013 [2] 13, 222 💬102. Viral myocarditis
|
||||||||||||||||||||||||||||||||||||
| 103 | Viral myocarditis 💬 2 genes, 5 drugs (DrugBank) and 7 diseases |
CD40LG [1] CD40LG 💬Viral myocarditis
|
Toralizumab Toralizumab 💬Viral myocarditis
| Toralizumab | 063 [1] 63 💬103. Viral myocarditis
|
||||||||||||||||||||||||||||||||||||
| 104 | Virion - Human immunodeficiency virus 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Virion - Human immunodeficiency virus
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Virion - Human immunodeficiency virus
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬104. Virion - Human immunodeficiency virus
|
||||||||||||||||||||||||||||||||||||
| 105 | Virion - Human immunodeficiency virus 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Virion - Human immunodeficiency virus
|
Zanolimumab Zanolimumab 💬Virion - Human immunodeficiency virus
| Zanolimumab | 046 [1] 46 💬105. Virion - Human immunodeficiency virus
|
||||||||||||||||||||||||||||||||||||
| 106 | Yersinia infection 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Virion - Human immunodeficiency virus
|
Anti-human thymocyte immunoglobulin, rabbit Anti-human thymocyte immunoglobulin, rabbit 💬Yersinia infection
| Antithymocyte immunoglobulin (rabbit) | 013 [13] 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬106. Yersinia infection
|
||||||||||||||||||||||||||||||||||||
| 107 | Yersinia infection 💬 1 gene, 2 drugs (DrugBank) and 14 diseases |
CD4 [1] CD4 💬Virion - Human immunodeficiency virus
|
Zanolimumab Zanolimumab 💬Yersinia infection
| Zanolimumab | 046 [1] 46 💬107. Yersinia infection
|
Allograft rejection
2 genes, 5 drugs (DrugBank) and 7 diseases
Antigen processing and presentation
1 gene, 2 drugs (DrugBank) and 14 diseases
Asthma
2 genes, 5 drugs (DrugBank) and 7 diseases
Autoimmune thyroid disease
2 genes, 5 drugs (DrugBank) and 7 diseases
Cell adhesion molecules
3 genes, 7 drugs (DrugBank) and 18 diseases
Cytokine-cytokine receptor interaction
3 genes, 7 drugs (DrugBank) and 18 diseases
Epstein-Barr virus infection
1 gene, 3 drugs (DrugBank) and 5 diseases
Hematopoietic cell lineage
1 gene, 2 drugs (DrugBank) and 14 diseases
Human immunodeficiency virus 1 infection
1 gene, 2 drugs (DrugBank) and 14 diseases
Human T-cell leukemia virus 1 infection
2 genes, 5 drugs (DrugBank) and 17 diseases
Intestinal immune network for IgA production
2 genes, 5 drugs (DrugBank) and 7 diseases
Lipid and atherosclerosis
2 genes, 5 drugs (DrugBank) and 7 diseases
Malaria
2 genes, 5 drugs (DrugBank) and 7 diseases
NF-kappa B signaling pathway
2 genes, 5 drugs (DrugBank) and 7 diseases
PD-L1 expression and PD-1 checkpoint pathway in cancer
1 gene, 2 drugs (DrugBank) and 14 diseases
Primary immunodeficiency
3 genes, 7 drugs (DrugBank) and 18 diseases
Systemic lupus erythematosus
2 genes, 5 drugs (DrugBank) and 7 diseases
T cell receptor signaling pathway
2 genes, 4 drugs (DrugBank) and 16 diseases
Th1 and Th2 cell differentiation
1 gene, 2 drugs (DrugBank) and 14 diseases
Th17 cell differentiation
1 gene, 2 drugs (DrugBank) and 14 diseases
Toll-like receptor signaling pathway
1 gene, 3 drugs (DrugBank) and 5 diseases
Toxoplasmosis
2 genes, 5 drugs (DrugBank) and 7 diseases
Transcriptional misregulation in cancer
1 gene, 3 drugs (DrugBank) and 5 diseases
Viral life cycle - HIV-1
1 gene, 2 drugs (DrugBank) and 14 diseases
Viral myocarditis
2 genes, 5 drugs (DrugBank) and 7 diseases
Virion - Human immunodeficiency virus
1 gene, 2 drugs (DrugBank) and 14 diseases
Yersinia infection
1 gene, 2 drugs (DrugBank) and 14 diseases
